Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 180

1.

Safety and immunogenicity study of Multiclade HIV-1 adenoviral vector vaccine alone or as boost following a multiclade HIV-1 DNA vaccine in Africa.

Jaoko W, Karita E, Kayitenkore K, Omosa-Manyonyi G, Allen S, Than S, Adams EM, Graham BS, Koup RA, Bailer RT, Smith C, Dally L, Farah B, Anzala O, Muvunyi CM, Bizimana J, Tarragona-Fiol T, Bergin PJ, Hayes P, Ho M, Loughran K, Komaroff W, Stevens G, Thomson H, Boaz MJ, Cox JH, Schmidt C, Gilmour J, Nabel GJ, Fast P, Bwayo J.

PLoS One. 2010 Sep 21;5(9):e12873. doi: 10.1371/journal.pone.0012873.

2.

Characterization of an HLA-C-restricted CTL response in chronic HIV infection.

Makadzange AT, Gillespie G, Dong T, Kiama P, Bwayo J, Kimani J, Plummer F, Easterbrook P, Rowland-Jones SL.

Eur J Immunol. 2010 Apr;40(4):1036-41. doi: 10.1002/eji.200939634.

3.
4.

Mucosal Neisseria gonorrhoeae coinfection during HIV acquisition is associated with enhanced systemic HIV-specific CD8 T-cell responses.

Sheung A, Rebbapragada A, Shin LY, Dobson-Belaire W, Kimani J, Ngugi E, MacDonald KS, Bwayo JJ, Moses S, Gray-Owen S, Kaul R; Kibera HIV Study Group.

AIDS. 2008 Sep 12;22(14):1729-37. doi: 10.1097/QAD.0b013e32830baf5e.

PMID:
18753933
5.

An evaluation of intravaginal rings as a potential HIV prevention device in urban Kenya: behaviors and attitudes that might influence uptake within a high-risk population.

Smith DJ, Wakasiaka S, Hoang TD, Bwayo JJ, Del Rio C, Priddy FH.

J Womens Health (Larchmt). 2008 Jul-Aug;17(6):1025-34. doi: 10.1089/jwh.2007.0529.

6.

Coinfection with herpes simplex virus type 2 is associated with reduced HIV-specific T cell responses and systemic immune activation.

Sheth PM, Sunderji S, Shin LY, Rebbapragada A, Huibner S, Kimani J, Macdonald KS, Ngugi E, Bwayo JJ, Moses S, Kovacs C, Loutfy M, Kaul R.

J Infect Dis. 2008 May 15;197(10):1394-401. doi: 10.1086/587697.

PMID:
18444797
7.

Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa.

Jaoko W, Nakwagala FN, Anzala O, Manyonyi GO, Birungi J, Nanvubya A, Bashir F, Bhatt K, Ogutu H, Wakasiaka S, Matu L, Waruingi W, Odada J, Oyaro M, Indangasi J, Ndinya-Achola J, Konde C, Mugisha E, Fast P, Schmidt C, Gilmour J, Tarragona T, Smith C, Barin B, Dally L, Johnson B, Muluubya A, Nielsen L, Hayes P, Boaz M, Hughes P, Hanke T, McMichael A, Bwayo J, Kaleebu P.

Vaccine. 2008 May 23;26(22):2788-95. doi: 10.1016/j.vaccine.2008.02.071. Epub 2008 Mar 31.

PMID:
18440674
8.

HIV-neutralizing immunoglobulin A and HIV-specific proliferation are independently associated with reduced HIV acquisition in Kenyan sex workers.

Hirbod T, Kaul R, Reichard C, Kimani J, Ngugi E, Bwayo JJ, Nagelkerke N, Hasselrot K, Li B, Moses S; Kibera HIV Study Group, MacDonald KS, Broliden K.

AIDS. 2008 Mar 30;22(6):727-35. doi: 10.1097/QAD.0b013e3282f56b64.

PMID:
18356602
9.

HIV-1 neutralizing activity is correlated with increased levels of chemokines in saliva of HIV-1-exposed uninfected individuals.

Hirbod T, Reichard C, Hasselrot K, Söderlund J, Kimani J, Bwayo JJ, Plummer F, Kaul R, Broliden K.

Curr HIV Res. 2008 Jan;6(1):28-33.

PMID:
18288972
10.

Persistently HIV-1 seronegative Nairobi sex workers are susceptible to in vitro infection.

Bienzle D, Macdonald KS, Copeland KF, Bwayo JJ, Plummer FA, Rosenthal KL.

Can J Infect Dis. 2000 Sep;11(5):259-63.

11.

Prevalent herpes simplex virus type 2 infection is associated with altered vaginal flora and an increased susceptibility to multiple sexually transmitted infections.

Kaul R, Nagelkerke NJ, Kimani J, Ngugi E, Bwayo JJ, Macdonald KS, Rebbaprgada A, Fonck K, Temmerman M, Ronald AR, Moses S; Kibera HIV Study Group.

J Infect Dis. 2007 Dec 1;196(11):1692-7. Epub 2007 Oct 25.

PMID:
18008255
12.

Sustained changes in sexual behavior by female sex workers after completion of a randomized HIV prevention trial.

Ngugi EN, Chakkalackal M, Sharma A, Bukusi E, Njoroge B, Kimani J, MacDonald KS, Bwayo JJ, Cohen CR, Moses S, Kaul R; Kibera HIV Study Group.

J Acquir Immune Defic Syndr. 2007 Aug 15;45(5):588-94.

PMID:
17589374
13.

Relationship between markers of HIV-1 disease progression and serum beta-carotene concentrations in Kenyan women.

Baeten JM, McClelland RS, Wener MH, Bankson DD, Lavreys L, Mandaliya K, Bwayo JJ, Kreiss JK.

Int J STD AIDS. 2007 Mar;18(3):202-6.

PMID:
17362556
14.

Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: effects of dosage and route on safety and immunogenicity.

Peters BS, Jaoko W, Vardas E, Panayotakopoulos G, Fast P, Schmidt C, Gilmour J, Bogoshi M, Omosa-Manyonyi G, Dally L, Klavinskis L, Farah B, Tarragona T, Bart PA, Robinson A, Pieterse C, Stevens W, Thomas R, Barin B, McMichael AJ, McIntyre JA, Pantaleo G, Hanke T, Bwayo J.

Vaccine. 2007 Mar 1;25(11):2120-7. Epub 2006 Nov 27.

PMID:
17250931
15.

Strong TCR conservation and altered T cell cross-reactivity characterize a B*57-restricted immune response in HIV-1 infection.

Gillespie GM, Stewart-Jones G, Rengasamy J, Beattie T, Bwayo JJ, Plummer FA, Kaul R, McMichael AJ, Easterbrook P, Dong T, Jones EY, Rowland-Jones SL.

J Immunol. 2006 Sep 15;177(6):3893-902.

16.

HIV-1 infection alters the retinol-binding protein:transthyretin ratio even in the absence of the acute phase response.

Baeten JM, Wener MH, Bankson DD, Lavreys L, Richardson BA, Mandaliya K, Bwayo JJ, McClelland RS.

J Nutr. 2006 Jun;136(6):1624-9.

PMID:
16702331
17.

Acceptability of human immunodeficiency virus testing in patients with invasive cervical cancer in Kenya.

Gichangi P, Estambale B, Bwayo J, Rogo K, Ojwang S, Njuguna E, Temmerman M.

Int J Gynecol Cancer. 2006 Mar-Apr;16(2):681-5.

PMID:
16681747
18.

Identification of a novel HLA B*57 restricted cytotoxic T-lymphocyte epitope within HIV-1 rev.

Makadzange AT, Gillespie G, Kimani J, Kiama P, Easterbrook P, Bwayo JJ, Rowland-Jones SL.

AIDS. 2006 Feb 14;20(3):462-4.

PMID:
16439884
19.

HIV impact on acute morbidity and pelvic tumor control following radiotherapy for cervical cancer.

Gichangi P, Bwayo J, Estambale B, Rogo K, Njuguna E, Ojwang S, Temmerman M.

Gynecol Oncol. 2006 Feb;100(2):405-11. Epub 2005 Nov 4.

PMID:
16274737
20.

Congenital syphilis in a Nairobi maternity hospital.

Gichangi P, Renterghem LV, Karanja J, Bwayo J, Kiragu D, Temmerman M.

East Afr Med J. 2004 Nov;81(11):589-93.

PMID:
15868969
21.

Comparison of pap smear, visual inspection with acetic acid, human papillomavirus DNA-PCR testing and cervicography.

De Vuyst H, Claeys P, Njiru S, Muchiri L, Steyaert S, De Sutter P, Van Marck E, Bwayo J, Temmerman M.

Int J Gynaecol Obstet. 2005 May;89(2):120-6.

PMID:
15847874
22.

Associations of sexual risk taking among Kenyan female sex workers after enrollment in an HIV-1 prevention trial.

Yadav G, Saskin R, Ngugi E, Kimani J, Keli F, Fonck K, Macdonald KS, Bwayo JJ, Temmerman M, Moses S, Kaul R; Kibera HIV Study Group.

J Acquir Immune Defic Syndr. 2005 Mar 1;38(3):329-34.

PMID:
15735453
23.

Female-to-male infectivity of HIV-1 among circumcised and uncircumcised Kenyan men.

Baeten JM, Richardson BA, Lavreys L, Rakwar JP, Mandaliya K, Bwayo JJ, Kreiss JK.

J Infect Dis. 2005 Feb 15;191(4):546-53. Epub 2005 Jan 18.

PMID:
15655778
24.

Construction of an infectious HIV type 1 molecular clone from an African patient with a subtype D/C Recombinant Virus.

Shi B, Philpott SM, Weiser B, Kuiken C, Brunner C, Fang G, Fowke KR, Plummer FA, Rowland-Jones S, Bwayo J, Anzala AO, Kimani J, Kaul R, Burger H.

AIDS Res Hum Retroviruses. 2004 Sep;20(9):1015-8.

PMID:
15585089
25.

HIV-1 Env-specific cytotoxic T-lymphocyte responses in exposed, uninfected Kenyan sex workers: a prospective analysis.

Kaul R, Rutherford J, Rowland-Jones SL, Kimani J, Onyango JI, Fowke K, MacDonald K, Bwayo JJ, McMichael AJ, Plummer FA.

AIDS. 2004 Oct 21;18(15):2087-9.

PMID:
15577632
26.

Micronutrient supplementation increases genital tract shedding of HIV-1 in women: results of a randomized trial.

McClelland RS, Baeten JM, Overbaugh J, Richardson BA, Mandaliya K, Emery S, Lavreys L, Ndinya-Achola JO, Bankson DD, Bwayo JJ, Kreiss JK.

J Acquir Immune Defic Syndr. 2004 Dec 15;37(5):1657-63.

PMID:
15577425
27.

Long-term survivors in Nairobi: complete HIV-1 RNA sequences and immunogenetic associations.

Fang G, Kuiken C, Weiser B, Rowland-Jones S, Plummer F, Chen CH, Kaul R, Anzala AO, Bwayo J, Kimani J, Philpott SM, Kitchen C, Sinsheimer JS, Gaschen B, Lang D, Shi B, Kemal KS, Rostron T, Brunner C, Beddows S, Sattenau Q, Paxinos E, Oyugi J, Burger H.

J Infect Dis. 2004 Aug 15;190(4):697-701. Epub 2004 Jul 13.

PMID:
15272396
28.

Shedding of human herpesvirus 8 in oral and genital secretions from HIV-1-seropositive and -seronegative Kenyan women.

Taylor MM, Chohan B, Lavreys L, Hassan W, Huang ML, Corey L, Ashley Morrow R, Richardson BA, Mandaliya K, Ndinya-Achola J, Bwayo J, Kreiss J.

J Infect Dis. 2004 Aug 1;190(3):484-8. Epub 2004 Jul 7.

PMID:
15243920
29.

Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: a randomized controlled trial.

Kaul R, Kimani J, Nagelkerke NJ, Fonck K, Ngugi EN, Keli F, MacDonald KS, Maclean IW, Bwayo JJ, Temmerman M, Ronald AR, Moses S; Kibera HIV Study Group.

JAMA. 2004 Jun 2;291(21):2555-62.

PMID:
15173146
30.

Human herpesvirus 8 seroconversion in Kenyan women by enzyme-linked immunosorbent assay and immunofluorescence assay.

Chohan BH, Taylor H, Obrigewitch R, Lavreys L, Richardson BA, Mandaliya KN, Bwayo JJ, Kreiss JK, Morrow RA.

J Clin Virol. 2004 Jun;30(2):137-44.

PMID:
15125869
31.

Gender differences in health care-seeking behavior for sexually transmitted diseases: a population-based study in Nairobi, Kenya.

Voeten HA, O'hara HB, Kusimba J, Otido JM, Ndinya-Achola JO, Bwayo JJ, Varkevisser CM, Habbema JD.

Sex Transm Dis. 2004 May;31(5):265-72.

PMID:
15107627
32.

Recombination following superinfection by HIV-1.

Fang G, Weiser B, Kuiken C, Philpott SM, Rowland-Jones S, Plummer F, Kimani J, Shi B, Kaul R, Bwayo J, Anzala O, Burger H.

AIDS. 2004 Jan 23;18(2):153-9.

PMID:
15075531
33.

Vitamin A supplementation and genital shedding of herpes simplex virus among HIV-1-infected women: a randomized clinical trial.

Baeten JM, McClelland RS, Corey L, Overbaugh J, Lavreys L, Richardson BA, Wald A, Mandaliya K, Bwayo JJ, Kreiss JK.

J Infect Dis. 2004 Apr 15;189(8):1466-71. Epub 2004 Apr 2.

PMID:
15073684
34.

A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans.

Mwau M, Cebere I, Sutton J, Chikoti P, Winstone N, Wee EG, Beattie T, Chen YH, Dorrell L, McShane H, Schmidt C, Brooks M, Patel S, Roberts J, Conlon C, Rowland-Jones SL, Bwayo JJ, McMichael AJ, Hanke T.

J Gen Virol. 2004 Apr;85(Pt 4):911-9.

PMID:
15039533
35.

Partner notification in the management of sexually transmitted infections in Nairobi, Kenya.

Wakasiaka SN, Bwayo JJ, Weston K, Mbithi J, Ogol C.

East Afr Med J. 2003 Dec;80(12):646-51.

PMID:
15018422
36.

Use of serum retinol-binding protein for prediction of vitamin A deficiency: effects of HIV-1 infection, protein malnutrition, and the acute phase response.

Baeten JM, Richardson BA, Bankson DD, Wener MH, Kreiss JK, Lavreys L, Mandaliya K, Bwayo JJ, McClelland RS.

Am J Clin Nutr. 2004 Feb;79(2):218-25.

PMID:
14749226
37.

Knowledge and practice about cervical cancer and Pap smear testing among patients at Kenyatta National Hospital, Nairobi, Kenya.

Gichangi P, Estambale B, Bwayo J, Rogo K, Ojwang S, Opiyo A, Temmerman M.

Int J Gynecol Cancer. 2003 Nov-Dec;13(6):827-33.

PMID:
14675320
38.

Impact of HIV infection on invasive cervical cancer in Kenyan women.

Gichangi PB, Bwayo J, Estambale B, De Vuyst H, Ojwang S, Rogo K, Abwao H, Temmerman M.

AIDS. 2003 Sep 5;17(13):1963-8.

PMID:
12960829
39.

Quantitative ex vivo analysis of functional virus-specific CD8 T lymphocytes in the blood and genital tract of HIV-infected women.

Kaul R, Thottingal P, Kimani J, Kiama P, Waigwa CW, Bwayo JJ, Plummer FA, Rowland-Jones SL.

AIDS. 2003 May 23;17(8):1139-44.

PMID:
12819514
40.

Traditional healers and the management of sexually transmitted diseases in Nairobi, Kenya.

Kusimba J, Voeten HA, O'Hara HB, Otido JM, Habbema JD, Ndinya-Achola JO, Bwayo JJ.

Int J STD AIDS. 2003 Mar;14(3):197-201.

PMID:
12665444
41.

Childcare practices of commercial sex workers.

Chege MN, Kabiru EW, Mbithi JN, Bwayo JJ.

East Afr Med J. 2002 Jul;79(7):382-9.

PMID:
12638835
42.
43.

Correlation between maternal and infant HIV infection and low birth weight: a study in Mombasa, Kenya.

Mwanyumba F, Claeys P, Gaillard P, Verhofstede C, Chohan V, Mandaliya K, Ndinya-Achola J, Bwayo J, Temmerman M.

J Obstet Gynaecol. 2001 Jan;21(1):27-31.

PMID:
12521907
44.

The effect of rapid HIV-1 testing on uptake of perinatal HIV-1 interventions: a randomized clinical trial.

Malonza IM, Richardson BA, Kreiss JK, Bwayo JJ, Stewart GC.

AIDS. 2003 Jan 3;17(1):113-8.

45.

Association between cervical shedding of herpes simplex virus and HIV-1.

McClelland RS, Wang CC, Overbaugh J, Richardson BA, Corey L, Ashley RL, Mandaliya K, Ndinya-Achola J, Bwayo JJ, Kreiss JK.

AIDS. 2002 Dec 6;16(18):2425-30.

PMID:
12461416
46.

Vitamin A deficiency and the acute phase response among HIV-1-infected and -uninfected women in Kenya.

Baeten JM, McClelland RS, Richardson BA, Bankson DD, Lavreys L, Wener MH, Overbaugh J, Mandaliya K, Ndinya-Achola JO, Bwayo JJ, Kreiss JK.

J Acquir Immune Defic Syndr. 2002 Oct 1;31(2):243-9.

PMID:
12394804
47.

Correlates of human herpesvirus 8 seropositivity among heterosexual men in Kenya.

Baeten JM, Chohan BH, Lavreys L, Rakwar JP, Ashley R, Richardson BA, Mandaliya K, Bwayo JJ, Kreiss JK.

AIDS. 2002 Oct 18;16(15):2073-8.

PMID:
12370507
48.

HLA typing in a Kenyan cohort identifies novel class I alleles that restrict cytotoxic T-cell responses to local HIV-1 clades.

Bird TG, Kaul R, Rostron T, Kimani J, Embree J, Dunn PP, Bwayo JJ, Plummer FA, Rowland-Jones SL, Dong T; Oxford-Nairobi HLA Collaborative Group.

AIDS. 2002 Sep 27;16(14):1899-904.

PMID:
12351949
49.

HLA-A and HLA-B in Kenya, Africa: allele frequencies and identification of HLA-B*1567 and HLA-B*4426.

Luo M, Embree J, Ramdahin S, Ndinya-Achola J, Njenga S, Bwayo JB, Pan S, Mao X, Cheang M, Stuart T, Brunham RC, Plummer FA.

Tissue Antigens. 2002 May;59(5):370-80.

PMID:
12144620
50.

Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects.

Devito C, Hinkula J, Kaul R, Kimani J, Kiama P, Lopalco L, Barass C, Piconi S, Trabattoni D, Bwayo JJ, Plummer F, Clerici M, Broliden K.

J Acquir Immune Defic Syndr. 2002 Aug 1;30(4):413-20.

PMID:
12138348

Supplemental Content

Support Center